Special Issue on

Recent Trends of Chemotherapy for Cancer

Chemotherapy (chemo) usually refers to the use of chemical substances to treat cancer. Rapid cell division is one of the main properties of most cancer cells. Traditional chemotherapeutic agents are cytotoxic. They can kill cancer cells that divide rapidly, while also can harm healthy cells that divide quickly under normal circumstances and damage to healthy cells may cause side effects. Here come some newer anticancer drugs, which are not indiscriminately cytotoxic, but target proteins that are abnormally expressed in cancer cells. They are sometimes used alone but are usually given in combination with traditional chemotherapy.

In this special issue, we intend to invite front-line researchers and authors to submit original research and review articles on exploring Recent Trends of Chemotherapy for Cancer. Potential topics include, but are not limited to:

• Induction chemotherapy
• Consolidation chemotherapy
• Combination chemotherapy
• Neoadjuvant chemotherapy
• Adjuvant chemotherapy
• Maintenance chemotherapy
• Salvage chemotherapy
• Cytotoxic antibiotics
• Adverse effects

Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal’s Paper Submission System.

Please kindly specify the “Special Issue” under your manuscript title. The research field “Special Issue - Recent Trends of Chemotherapy for Cancer” should be selected during your submission.

Special Issue Timetable:

Guest Editor:

For further questions or inquiries, please contact Editorial Assistant at

jct@scirp.org.